| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-07 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-07 |
| mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-07 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
5e-07 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-07 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |
| mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-06 |
| mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |